Atorvastatin Calcium
Product Images NDC 68071-4267

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 68071-4267). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

68071 4267 9

68071 4267 9
This is a description of a medication called Atorvastatin Calcium 40mg being manufactured by NuCare Pharmaceuticals, Inc. The medication comes in a bottle containing 90 tablets and the lot number is 000000. The NDC number is 68071-4267-09 and the manufacturing NDC number is 60505-2580-9. The expiration date of the medication is 00-00. The medication is meant for prescription-only and the user is advised to keep it out of reach of children and store it at a controlled temperature of 59-86°F. The user is advised to call their doctor in case of any side effects and maybe report any such effects to the FDA at 1-800-FDA-1088.*
FDA Label Image

Figure-01 (Figure 01)

FDA Label Image

Figure-02 (Figure 02)

Figure-02 (Figure 02)
The text seems to be a graph displaying the cumulative hazard percentage with a comparison of Atorvastatin and placebo drugs over a period of four years. The hazard ratio for Atorvastatin is 0.53 with a confidence interval of 0.45 to 0.83. However, the graph is not fully decipherable from the given text.*
FDA Label Image

Figure-03 (Figure 03)

Figure-03 (Figure 03)
This text represents the percentage of subjects experiencing E vert after being administered two different dosages of cholesterol-lowering drugs - Horvastatin 10mg and Sorvastatin 80mg. A statistical analysis of the data shows that Horvastatin resulted in a 22% reduction (HR 0.78) in the risk of major cardiovascular events compared to Sorvastatin. The HR value has a confidence interval (CI) of 0.69-0.89 and a P=0.0002 indicating statistical significance. The text also presents a graph showing the time to the first major cardiovascular endpoint in years.*
FDA Label Image

Chemical-structure (Chemical Structure)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.